TORONTO, May 14, 2021 /CNW/ - Peter Rands, Chief Executive Officer, Small
Pharma Inc. ("Small Pharma" or "the Company") (TSXV: DMT), and his
team joined Dani Lipkin, Director,
Global Business Development TMX Group, to celebrate the Company's
new listing on TSX Venture Exchange and open the market.
Small Pharma is a neuropharmaceutical company specialised in IP
led development of novel treatments for mental health conditions,
with a focus on depression. Small Pharma initiated a clinical
program into DMT assisted therapy in February 2021. This program includes a Phase
I/IIa trial on their lead candidate alongside development of a
robust pipeline of proprietary preclinical assets. For more
information visit https://www.smallpharma.co.uk/.
For Market Openings: Media may pick up a feed
from the TOC (television operations centre) for all market open
ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is
produced at the TMX Broadcast Centre and sent live to the TOC. To
pick up the feed via the Dejero network, please contact
avservices@tmx.com. The client feature video will begin playing on
the TMX media wall at approximately 9:27
a.m. ET and the markets will open with the sound of a siren
at 9:30 a.m. ET
Date: Friday, May
14, 2021
Time:
9:00am -
9:30am
Place: Virtually Broadcast
SOURCE TSX Venture Exchange
